BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol. 2004;68:2367-2378. [PMID: 15548383 DOI: 10.1016/j.bcp.2004.08.022] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Ciccaglione AR, Marcantonio C, Tritarelli E, Tataseo P, Ferraris A, Bruni R, Dallapiccola B, Gerosolimo G, Costantino A, Rapicetta M. Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones. BMC Genomics 2008;9:309. [PMID: 18590516 DOI: 10.1186/1471-2164-9-309] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang G, Chen S, Zhao C, Li X, Zhao W, Yang J, Chang C, Xu C. Comparative analysis of gene expression profiles of OPN signalling pathway in four kinds of liver diseases. J Genet 2016;95:741-50. [DOI: 10.1007/s12041-016-0673-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Chen Y, Ou Y, Dong J, Yang G, Zeng Z, Liu Y, Liu B, Li W, He X, Lan T. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition. Exp Cell Res 2018;362:343-8. [PMID: 29196165 DOI: 10.1016/j.yexcr.2017.11.035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
4 Gnainsky Y, Kushnirsky Z, Bilu G, Hagai Y, Genina O, Volpin H, Bruck R, Spira G, Nagler A, Kawada N. Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. Cell Tissue Res. 2007;328:153-166. [PMID: 17180598 DOI: 10.1007/s00441-006-0330-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
5 Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 1-87. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Song J, Ge Z, Yang X, Luo Q, Wang C, You H, Ge T, Deng Y, Lin H, Cui Y. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin. Cancer Lett. 2015;356:713-720. [PMID: 25449435 DOI: 10.1016/j.canlet.2014.10.021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
7 Tran A, Gual P. Non-alcoholic steatohepatitis in morbidly obese patients. Clin Res Hepatol Gastroenterol. 2013;37:17-29. [PMID: 23347840 DOI: 10.1016/j.clinre.2012.07.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
8 Hu X, Tanaka N, Guo R, Lu Y, Nakajima T, Gonzalez FJ, Aoyama T. PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis. J Nutr Biochem 2017;39:77-85. [PMID: 27816763 DOI: 10.1016/j.jnutbio.2016.09.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
9 Chen BL, Zhang GY, Yuan WJ, Wang SP, Shen YM, Yan L, Gu H, Li J. Osteopontin expression is associated with hepatopathologic changes in Schistosoma japonicum infected mice. World J Gastroenterol 2011; 17(46): 5075-5082 [PMID: 22171141 DOI: 10.3748/wjg.v17.i46.5075] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
10 Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation. World J Gastroenterol 2014; 20(36): 13088-13104 [PMID: 25278703 DOI: 10.3748/wjg.v20.i36.13088] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
11 Pascut D, Pratama MY, Vo NVT, Masadah R, Tiribelli C. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications. Cancers (Basel) 2020;12:E823. [PMID: 32235370 DOI: 10.3390/cancers12040823] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
12 Brzezicki G, Jankowski R, Blok T, Klimczak A, Szymas J, Huber J, Szukala A, Siemionow M, Nowak S. Postlaminectomy osteopontin expression and associated neurophysiological findings in rat peridural scar model. Spine (Phila Pa 1976) 2011;36:378-85. [PMID: 20838370 DOI: 10.1097/BRS.0b013e3181d12ef4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
13 Bohanon FJ, Wang X, Graham BM, Prasai A, Vasudevan SJ, Ding C, Ding Y, Radhakrishnan GL, Rastellini C, Zhou J, Radhakrishnan RS. Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells. Mol Cell Biochem 2015;410:293-300. [PMID: 26346163 DOI: 10.1007/s11010-015-2562-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wiwanitkit V. Effect of interleukin-2 and tumor necrosis factor-alpha on osteopontin: molecular function and biological process. Pediatr Int 2008;50:213-5. [PMID: 18353062 DOI: 10.1111/j.1442-200X.2008.02561.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Walkin L, Herrick SE, Summers A, Brenchley PE, Hoff CM, Korstanje R, Margetts PJ. The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. Fibrogenesis Tissue Repair 2013;6:18. [PMID: 24294831 DOI: 10.1186/1755-1536-6-18] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 10.0] [Reference Citation Analysis]
16 Sahai A, Pan X, Paul R, Malladi P, Kohli R, Whitington PF. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium. Am J Physiol Gastrointest Liver Physiol. 2006;291:G55-G62. [PMID: 16439472 DOI: 10.1152/ajpgi.00360.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
17 Woo SW, Hwang KI, Chung MW, Jin SK, Bang S, Lee SH, Lee SH, Chung HJ, Sohn DH. Gene expression profiles during the activation of rat hepatic stellate cells evaluated by cDNA microarray. Arch Pharm Res. 2007;30:1410-1418. [PMID: 18087809 DOI: 10.1007/bf02977365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Sommerhalder C, Cummins CB, Wang X, Ramdas D, Lopez ON, Gu Y, Zhou J, Radhakrishnan RS. HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways. J Surg Res 2021;261:334-42. [PMID: 33486415 DOI: 10.1016/j.jss.2020.12.045] [Reference Citation Analysis]
19 Schon HT, Bartneck M, Borkham-Kamphorst E, Nattermann J, Lammers T, Tacke F, Weiskirchen R. Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis. Front Pharmacol 2016;7:33. [PMID: 26941644 DOI: 10.3389/fphar.2016.00033] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 8.8] [Reference Citation Analysis]
20 Lorena D, Darby IA, Gadeau AP, Leen LL, Rittling S, Porto LC, Rosenbaum J, Desmoulière A. Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice. J Hepatol. 2006;44:383-390. [PMID: 16221502 DOI: 10.1016/j.jhep.2005.07.024] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 3.9] [Reference Citation Analysis]
21 Mannaerts I, Schroyen B, Verhulst S, Van Lommel L, Schuit F, Nyssen M, van Grunsven LA. Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration. PLoS One 2013;8:e84071. [PMID: 24358328 DOI: 10.1371/journal.pone.0084071] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
22 Machado MV, Cortez-Pinto H. Osteopontin: a missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis. Hepatology 2011;53:382-4. [PMID: 21274859 DOI: 10.1002/hep.24118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
23 Cummins CB, Wang X, Nunez Lopez O, Graham G, Tie HY, Zhou J, Radhakrishnan RS. Luteolin-Mediated Inhibition of Hepatic Stellate Cell Activation via Suppression of the STAT3 Pathway. Int J Mol Sci 2018;19:E1567. [PMID: 29795016 DOI: 10.3390/ijms19061567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
24 Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract. 2008;62:1056-1062. [PMID: 17537188 DOI: 10.1111/j.1742-1241.2007.01368.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
25 Haybaeck J, Stumptner C, Thueringer A, Kolbe T, Magin TM, Hesse M, Fickert P, Tsybrovskyy O, Müller H, Trauner M, Zatloukal K, Denk H. Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model. Lab Invest 2012;92:857-67. [PMID: 22449798 DOI: 10.1038/labinvest.2012.49] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
26 Saika S, Shirai K, Yamanaka O, Miyazaki K, Okada Y, Kitano A, Flanders KC, Kon S, Uede T, Kao WW, Rittling SR, Denhardt DT, Ohnishi Y. Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium. Lab Invest 2007;87:130-8. [PMID: 17211411 DOI: 10.1038/labinvest.3700508] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
27 Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, Oo YH, Mi Z, Pereira TA, Zdanowicz M, Malladi P. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology. 2011;53:106-115. [PMID: 20967826 DOI: 10.1002/hep.23998] [Cited by in Crossref: 163] [Cited by in F6Publishing: 159] [Article Influence: 14.8] [Reference Citation Analysis]
28 Wijaya RS, Read SA, Schibeci S, Eslam M, Azardaryany MK, El-Khobar K, van der Poorten D, Lin R, Yuen L, Lam V, George J, Douglas MW, Ahlenstiel G. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. J Hepatol 2019;71:252-64. [PMID: 30905683 DOI: 10.1016/j.jhep.2019.03.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
29 Matsue Y, Tsutsumi M, Hayashi N, Saito T, Tsuchishima M, Toshikuni N. Serum Osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection. PLoS One. 2015;10:e0118744. [PMID: 25760884 DOI: 10.1371/journal.pone.0118744] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
30 Ogawa T, Tateno C, Asahina K, Fujii H, Kawada N, Obara M, Yoshizato K. Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts. Histochem Cell Biol 2007;127:161-74. [DOI: 10.1007/s00418-006-0237-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
31 Iqbal J, McRae S, Mai T, Banaudha K, Sarkar-Dutta M, Waris G. Role of hepatitis C virus induced osteopontin in epithelial to mesenchymal transition, migration and invasion of hepatocytes. PLoS One 2014;9:e87464. [PMID: 24498111 DOI: 10.1371/journal.pone.0087464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
32 Imran M, Manzoor S, Parvaiz F. Predictive potential of IL-18 -607 and osteopontin -442 polymorphism in interferon-based therapy of HCV infection in the Pakistani population. Viral Immunol 2014;27:404-11. [PMID: 25198668 DOI: 10.1089/vim.2014.0044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
33 Leung TM, Wang X, Kitamura N, Fiel MI, Nieto N. Osteopontin delays resolution of liver fibrosis. Lab Invest. 2013;93:1082-1089. [PMID: 23999249 DOI: 10.1038/labinvest.2013.104] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
34 Andrews S, Ford D, Martin P. Knockdown of osteopontin reduces the inflammatory response and subsequent size of postsurgical adhesions in a murine model. Am J Pathol 2012;181:1165-72. [PMID: 22858059 DOI: 10.1016/j.ajpath.2012.06.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
35 Bohinc BN, Diehl AM. Mechanisms of disease progression in NASH: new paradigms. Clin Liver Dis. 2012;16:549-565. [PMID: 22824480 DOI: 10.1016/j.cld.2012.05.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
36 Lee SH, Seo GS, Jin XY, Ko G, Sohn DH. Butein blocks tumor necrosis factor alpha-induced interleukin 8 and matrix metalloproteinase 7 production by inhibiting p38 kinase and osteopontin mediated signaling events in HT-29 cells. Life Sci. 2007;81:1535-1543. [PMID: 17977560 DOI: 10.1016/j.lfs.2007.09.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
37 Wang X, Lopategi A, Ge X, Lu Y, Kitamura N, Urtasun R, Leung TM, Fiel MI, Nieto N. Osteopontin induces ductular reaction contributing to liver fibrosis. Gut. 2014;63:1805-1818. [PMID: 24496779 DOI: 10.1136/gutjnl-2013-306373] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 9.4] [Reference Citation Analysis]
38 White ES, Xia M, Murray S, Dyal R, Flaherty CM, Flaherty KR, Moore BB, Cheng L, Doyle TJ, Villalba J, Dellaripa PF, Rosas IO, Kurtis JD, Martinez FJ. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2016;194:1242-51. [PMID: 27149370 DOI: 10.1164/rccm.201505-0862OC] [Cited by in Crossref: 88] [Cited by in F6Publishing: 45] [Article Influence: 22.0] [Reference Citation Analysis]
39 Hertel PM, Crawford SE, Finegold MJ, Estes MK. Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia. Virology 2011;417:281-92. [PMID: 21742364 DOI: 10.1016/j.virol.2011.05.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
40 Nagoshi S. Osteopontin: Versatile modulator of liver diseases. Hepatol Res. 2014;44:22-30. [PMID: 23701387 DOI: 10.1111/hepr.12166] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
41 Bohanon FJ, Wang X, Ding C, Ding Y, Radhakrishnan GL, Rastellini C, Zhou J, Radhakrishnan RS. Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis. J Surg Res 2014;190:55-63. [PMID: 24742622 DOI: 10.1016/j.jss.2014.03.036] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
42 Shackel NA, Seth D, Haber PS, Gorrell MD, McCaughan GW. The hepatic transcriptome in human liver disease. Comp Hepatol 2006;5:6. [PMID: 17090326 DOI: 10.1186/1476-5926-5-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
43 Mori R, Shaw TJ, Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med. 2008;205:43-51. [PMID: 18180311 DOI: 10.1084/jem.20071412] [Cited by in Crossref: 198] [Cited by in F6Publishing: 194] [Article Influence: 15.2] [Reference Citation Analysis]
44 Shaker O, El-Shehaby A, Fayez S, Zahra A, Marzouk S, El Raziky M. Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4. Cell Biochem Funct. 2013;31:620-625. [PMID: 23400862 DOI: 10.1002/cbf.2954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
45 Huang W, Zhu G, Huang M, Lou G, Liu Y, Wang S. Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects. Clin Chim Acta. 2010;411:675-678. [PMID: 20138033 DOI: 10.1016/j.cca.2010.01.029] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
46 Arriazu E, Ruiz de Galarreta M, Cubero FJ, Varela-Rey M, Pérez de Obanos MP, Leung TM, Lopategi A, Benedicto A, Abraham-Enachescu I, Nieto N. Extracellular matrix and liver disease. Antioxid Redox Signal 2014;21:1078-97. [PMID: 24219114 DOI: 10.1089/ars.2013.5697] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 9.1] [Reference Citation Analysis]
47 Lee SH, Seo GS, Kim HS, Woo SW, Ko G, Sohn DH. 2′,4′,6′-Tris(methoxymethoxy) chalcone attenuates hepatic stellate cell proliferation by a heme oxygenase-dependent pathway. Biochemical Pharmacology 2006;72:1322-33. [DOI: 10.1016/j.bcp.2006.08.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
48 Jiroutova A, Slavkovsky R, Cermakova M, Majdiakova L, Hanovcova I, Bolehovska R, Hajzlerova M, Radilova H, Ruszova E, Kanta J. Expression of mRNAs related to connective tissue metabolism in rat hepatic stellate cells and myofibroblasts. Experimental and Toxicologic Pathology 2007;58:263-73. [DOI: 10.1016/j.etp.2006.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
49 Friedman SL. Extracellular matrix. In: Dufour J, Clavien P, editors. Signaling Pathways in Liver Diseases. Chichester: John Wiley & Sons, Ltd; 2015. pp. 85-96. [DOI: 10.1002/9781118663387.ch6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, Le Marchand-Brustel Y, Veillon P, Calès P, Perlemuter G, Tran A, Gual P. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 2012;7:e35612. [PMID: 22530059 DOI: 10.1371/journal.pone.0035612] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
51 Mannaerts I, Nuytten NR, Rogiers V, Vanderkerken K, van Grunsven LA, Geerts A. Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo. Hepatology 2010;51:603-14. [DOI: 10.1002/hep.23334] [Cited by in Crossref: 80] [Cited by in F6Publishing: 88] [Article Influence: 6.7] [Reference Citation Analysis]
52 Copple B, Allen K, Welch T. Mechanisms of Liver Fibrosis. Comprehensive Toxicology. Elsevier; 2010. pp. 263-74. [DOI: 10.1016/b978-0-08-046884-6.01011-3] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Weiskirchen R. Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. Front Pharmacol. 2015;6:303. [PMID: 26779021 DOI: 10.3389/fphar.2015.00303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
54 Crawford JM, Burt AD. Anatomy, pathophysiology and basic mechanisms of disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 1-77. [DOI: 10.1016/b978-0-7020-3398-8.00001-5] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
55 Tokairin T, Nishikawa Y, Watanabe H, Doi Y, Omori Y, Yoshioka T, Yamamoto Y, Yoshida M, Nishimura T, Li Q. Osteopontin expression in the liver with severe perisinusoidal fibrosis: autopsy case of Down syndrome with transient myeloproliferative disorder. Pathol Int. 2008;58:64-68. [PMID: 18067644 DOI: 10.1111/j.1440-1827.2007.02191.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
56 Xiao X, Gang Y, Gu Y, Zhao L, Chu J, Zhou J, Cai X, Zhang H, Xu L, Nie Y. Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation. Dig Dis Sci. 2012;57:2883-2891. [PMID: 22661273 DOI: 10.1007/s10620-012-2248-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
57 Iordanskaia T, Koeck E, Rossi C, Mohan P, Schwarz K, Anders R, Nadler EP. Integrin β-8, but not β-5 or -6, protein expression is increased in livers of children with biliary atresia. J Pediatr Gastroenterol Nutr 2014;59:679-83. [PMID: 25079481 DOI: 10.1097/MPG.0000000000000518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Cummins CB, Wang X, Xu J, Hughes BD, Ding Y, Chen H, Zhou J, Radhakrishnan RS. Antifibrosis Effect of Novel Oridonin Analog CYD0618 Via Suppression of the NF-κB Pathway. J Surg Res 2018;232:283-92. [PMID: 30463731 DOI: 10.1016/j.jss.2018.06.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
59 Pritchett J, Harvey E, Athwal V, Berry A, Rowe C, Oakley F, Moles A, Mann DA, Bobola N, Sharrocks AD. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology. 2012;56:1108-1116. [PMID: 22488688 DOI: 10.1002/hep.25758] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
60 Kuttippurathu L, Juskeviciute E, Dippold RP, Hoek JB, Vadigepalli R. A novel comparative pattern analysis approach identifies chronic alcohol mediated dysregulation of transcriptomic dynamics during liver regeneration. BMC Genomics 2016;17:260. [PMID: 27012785 DOI: 10.1186/s12864-016-2492-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
61 Fickert P, Stöger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol. 2007;171:525-536. [PMID: 17600122 DOI: 10.2353/ajpath.2007.061133] [Cited by in Crossref: 214] [Cited by in F6Publishing: 202] [Article Influence: 15.3] [Reference Citation Analysis]
62 Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI, Nieto N. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Hepatology. 2012;55:594-608. [PMID: 21953216 DOI: 10.1002/hep.24701] [Cited by in Crossref: 140] [Cited by in F6Publishing: 137] [Article Influence: 15.6] [Reference Citation Analysis]
63 戴文玲, 黄海峰, 陆翠华. 骨桥蛋白在肝纤维化组织中的表达及其与肝星状细胞活化的关系. 世界华人消化杂志 2013; 21(36): 4121-4126 [DOI: 10.11569/wcjd.v21.i36.4121] [Reference Citation Analysis]
64 Seth D, D’souza El-guindy NB, Apte M, Mari M, Dooley S, Neuman M, Haber PS, Kundu GC, Darwanto A, de Villiers WJ, Vonlaufen A, Xu Z, Phillips P, Yang S, Goldstein D, Pirola RM, Wilson JS, Moles A, Fernã¡ndez A, Colell A, Garcã­a-ruiz C, Fernã¡ndez-checa JC, Meyer C, Meindl-beinker NM. Alcohol, Signaling, and ECM Turnover. Alcoholism: Clinical and Experimental Research 2010;34:4-18. [DOI: 10.1111/j.1530-0277.2009.01060.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]